#United States #Detroit #Karmanos Cancer Institute #Stefan C. Grant #Cancer Network

Karmanos Cancer Institute Welcomes Dr. Stefan C. Grant

The Barbara Ann Karmanos Cancer Institute, a leader in cancer treatment and research located in Detroit, Michigan, has recently appointed Dr. Stefan C. Grant to a pivotal role within its organization. As the new associate center director and medical director of the Karmanos Cancer Network, Dr. Grant brings over thirty years of invaluable experience in medical oncology, particularly in lung cancer treatment.

Dr. Grant, who began his role in September, is set to oversee oncology operations across the Karmanos Cancer Network, which includes thirteen locations throughout Michigan. This strategic position not only involves administrative responsibilities but also a commitment to enhancing access to cutting-edge clinical trials for patients across the region. He will be collaborating closely with existing leadership, including Anthony Shields, the associate center director for Clinical Science, to ensure that oncology teams can offer comprehensive treatment options even outside of urban areas.

In expanding patient access to innovative treatments, Dr. Grant is focused on advancing the Karmanos mission of providing high-quality, patient-centered care. “The reason I chose to join Karmanos is its commitment to research and improving cancer care,” Dr. Grant stated during his introduction to the team. He aims to leverage his expertise in clinical trials to offer patients in Michigan better options, whether through standard care or novel therapies.

Known for his leadership roles in comprehensive cancer centers recognized by the National Cancer Institute (NCI), Dr. Grant has played a crucial role in maintaining and renewing these prestigious designations. His credentials and experiences speak volumes of his commitment and vision for integrating advanced cancer research into everyday clinical practice.

As medical director, Dr. Grant will oversee not only surgical oncology services but also enhance quality assurance and ensure that all services comply with NCI regulations. This is a crucial aspect of his role, as it will help maintain the standard of care Karmanos is known for. Dr. Boris Pasche, president and CEO of Karmanos, emphasized the importance of Dr. Grant's role by stating, “Creating a position like the associate center director and medical director reflects our goal to provide high-quality, compliant, and impactful clinical trials for our patients.”

Dr. Grant's expertise lies particularly in thoracic oncology, where he specializes in lung cancer (including both non-small cell and small cell varieties), pleural mesotheliomas, and related conditions. He is a recognized figure in lung cancer research, focusing on immunologic therapies, targeted treatments, and developing pragmatic clinical trials to address gaps in care.

With a strong academic background, Dr. Grant holds a medical degree from the University of the Witwatersrand in Johannesburg, along with a Juris Doctor from Fordham University and an MBA from the University of Alabama at Birmingham. He has shared his knowledge on several prestigious platforms, being a member of advisory panels for national cancer guidelines and serving as editor for respected medical journals.

Prior to his arrival at Karmanos, Dr. Grant was co-director at the Louisiana Cancer Research Center (LCRC) and held directorship roles at Tulane Cancer Center, demonstrating a rich history of leadership in oncology. His career path has taken him through various esteemed institutions across the United States, contributing significantly to the field of cancer medicine.

Dr. Grant sees patients at Karmanos’ locations in both Detroit and Farmington Hills and is committed to patient care that goes beyond treatment; he seeks to contribute solutions to challenges in current treatment standards and to explore new efficacies in patient care.

The Karmanos Cancer Institute continues to reinforce its role as a staple in Michigan's cancer care landscape. With Dr. Grant’s extensive experience and innovative approach to treatment, the organization is poised for a new chapter in its mission to redefine cancer care. For more information on Karmanos and to schedule an appointment, you can visit their website or contact them directly.